everyone. Robert, you, and welcome, Thank
which portfolios. on prescription were as we XXXX, positively focused operating was Since successfully our of we flows, its year drains which specialty of have and of which our indefinitely completed commenced, pediatric our our suspending repositioned on Consumer transformed winding this development clinical therapeutics novel Aytu. During and commercializing programs growing July in included ADHD both cash company in down a and of fiscal the Health repositioning XXXX, business, profile Aytu pharmaceutical consisting exclusively
adjusted at you improved our to fiscal 'XX, compared million was adjusted in back million. when look 'XX. negative EBITDA For XXX% to EBITDA fiscal And $X.X $XX.X fiscal 'XX, $X.X million a
a efforts achievement swing point. a we've by over our So X-year achieved them than team, more thank to million span, to Aytu us and entire Quite get results. this for $XX I their an the all positive operating in
down which, the in 'XX, tasked mentioned, but wind in As Health Consumer cash operating that had of team revenue this would sell with off associated indeed line. of to generate goals the business, Health June previous to Consumer did We were we our our year, flows. have business million we announced goal bottom year minimal expenses inventory impact the those positive and not with $XX.X And achieved. this to remaining past minimize
'XX. remaining fiscal been through were we Further, While down business assets. as monetize fiscal we end the effectively final of the selling consumer of costs, shut health at in consumer the to to quarter 'XX minimize first health has of looked ways inventory the disruption some
Again, to health private agreement an consumer we business this achieved our company. to entered was goal divest e-commerce-focused when a into
Consumer future Aytu of agreement, on As part the payments to of royalty products. of sales Health the will business up $X.X former million revenue-based receive now
valuation of to investors and to wind the a could profile we growth, going those believe the loop corporate our business, and down operating forward. clearly the for and visible to the scream Health the close Consumer margin of this We market company's be we that expansion, made As will believe lead re-rating profitability.
ago, as Prairie Texas part of the expenses of has of third-party requirements about transition to identification manufacturer It this was diligently manufacturer. successfully started COGS. acquired a commence organization ensure across aspect of been we with XX therefore, much what meet acquisition third-party initially have orderly fixed We ADHD our and facility, We to and the increased of efficiencies the U.S.-based of needed. consistent a received drive closure source Neos from our larger could a the months that of the manufacture was, strategic large key the overhead and Grand production line. to transfer product was a Another approval which the pivot since FDA the than to and manufacturing to process then our driver worked
facility some completed costs our continue through the the the for June gross ceased landlord. the and related end all facility the our the production gradual result purposes, have to been final we in in we prepare calendar margins. and manufacturing as to to 'XX run over intents using has past but will return year We in-house incur The to improvement facility
Aytu channel. phase the has company. operations this Prairie we I leadership believe more the it margin down on that next led gross were the ADHD maintained, intense to to team. last in realistic inventory the of into XX% an pediatric fiscal Rx following to margins mix This or and our getting during is want And through wind products, XX% been thank everyone Grand 'XX by old depending sold the process year. product see between compared less and important and we as involved time-consuming move
loan to of note. particularly gotten we process, histories. term loan brand's a The the a secured our term mid-June, we million impressed profitability through that inventory portion I'm new this $XX million among in more which In Eclipse, focus production to the secured $XX challenging our our amortizing aforementioned announced Aytu. levels, refinance replaces team us all to levels entered towards on products respective in term our favorable highest and have terms into a that position and pay transfer with driving maintained previous put on term down loan tech
basis $X.X in savings expense. interest XXX represented approximate point the at reduction the results potential time which Importantly, rate, an in million of this interest of in refinancing,
the of from years previous January liability note matures now. become a had 'XX. current matured X of in now in 'XX, as It XXXX it Additionally, -- June
balance periodic filings. the sheet to more with results, improves helping most current language the with and of improving amendment potential with our capacity, for indebtedness, to in resulted we from key extended increase XXXX maturity company. refinancing, note, also agreement overall providing the credit of facility operating borrowing of loan from the our to the long-term a advantageous other the Concurrently with our revolving June So term term financial terms liabilities in date Eclipse removal with along the along our reclassifying concern improve going ratios. decreases refinancing our has by This the of
So when step few I at look a I our back key take points, summarize a and sheet, our help improvements. think, balance
$XX of with quarters. consistent and First, million is our the December cash March position
portion end Second, million our of $X June. debt at than current the decreased long-term from of less the million to $XX March in
our total by loan, have potential from March. decreased rate million And decreased we savings with have provide Third, of our debt which million $X.X for term finally, we interest will in $X.X expense. associated the interest
possible Aytu enhance sincere these made of All and of been thanks could financial business. team improvements to without strategic on to significantly moves My the operating the profile the everyone that. the we for not have
share at we with Eclipse for and and relationship Also, support my thank to Avenue collaboration team the that their build. continue I with the the collaboration over want excitement to the us years last Capital to personally expand and few
unique business while drive of can RxConnect is a scale added is years tremendous benefits in the the our compared to capabilities also prescription patients With pricing. promotional to in believe position the in dramatically and current future. focus X ago, for growth innovative future and to leveraging on consistent to business that efficiencies improved and to mix highly our program, products continuing the provides core and prescribers leverageable RxConnect which revenue products we also is through transparent and our be enable our
revenue period net an ADHD and same second from that XXXX. our when in half fiscal year-over-year For the year-over-year X% the year experienced portfolio with the XX% increased comparing increase of year,
fluctuations issue looking the March way, by temporary to time June our corrected in in to we to judgment revenue at experienced impacting trends view the by January related albeit quarter, second the it's driven net the best a last frames. been Given since has year's through effects by payer the dramatic ADHD that significant and half, gross the
when at So fiscal again, half growth second rate, that to was X%. looking fiscal half, second
The when growth was ship up X% pleased a temporary we looking of Adzenys time taken September over this we X% up trajectory way impressive shortages over time normalized. year revenue the from with even prior half up most frame in and peaking last units And comparative as since the periods. the basis. shortage an year quarter, this which July across benefit And extremely the but we experienced from supply through positive we're ADHD achieved industry a last Adderall We're growth unit with place, when the scripts current benefited thus are on from XX. X this year-over-year still sales that normalization at having XX% from yesterday, have year
written be believe perspective, from before few today a significant level 'XX. up scripts number up That again and to fiscal in brands. XXX,XXX in ADHD normalized years stimulant more in to a XXX,XXX put stepped what for a in we in 'XX, were fiscal 'XX, XXX,XXX To shortages this there change to 'XX, the Importantly, $XXX,XXX is ago fiscal was step occurred. fiscal
an XXXX is all-time of very least. about We've an to reset to line above the the say and trend to So exciting well high. levels, the free XX% at from baseline increase which is shortage XXXX
the that upon Something I the touched impact from Change that attack upon subsidiary, last wanted expand UnitedHealthcare again impacted to Healthcare. I quarter was cyber
and with Healthcare, branded that be Change what to buydowns, savings enables cetera familiar, other not dispensing interacts co-pay essentially those programs, systems. switchboard through pharmacy is a For et programs, among things, processed reimbursement manufacturers,
resulted with companies reimbursement across services. systems extended time. effectively pricing impacted havoc that many health created Rx in pharma products paid going interacts their Among care of unfilled. periods things, patient coupon significantly prescriptions This, also this get to often working resulted cyber physician turn, It and access offices for programs ecosystem for billing the and and attack physician other in not in and many
the range co-pay to we quarter dispensing. The the to system last many was our such albeit particular, is chain higher of co-pays an sequential mentioned In that the our impact a largest likely grocery than customers some decrease effect our cards attack, industry. unable that in that traditional prescription in than make change cyber the one from XX% much $XX. were less in net others I process changes felt of
have our had So we QX to with this and experienced that additional was issues negative customer would impacted. impact on surely this negatively a consider temporary Couple ordering business.
back more to normalized and back and Max product co-pay for fixed, issue as are that to patients processing $XX they're now ordering is Fortunately, and finally, well. commercial
couple yesterday, of go, a I based days that Looking sales growth future XX% bit, will our ADHD expectation we volumes on are of still is read the to July the September up, business X see unit with through a preliminary to from as our XX. a data script said, as it
Now caveat unit that let me is growth. that, this
of revenue very we're So said, That mirror fiscal this to doesn't out pleased with we here and growth gross-to-net shipments as always round to distributors. variations QX. trends the due timing our
the 'XX. impacted of September On changes by to pediatric in payer be continues that our pediatric front, portfolio occurred back
However, of seeing touch signs here recovery numbers promising shortly. the we quarter. on those in first are very I'll
drifted fiscal pediatric revenue during $XX.X million further scripts the $X.X fiscal million. 'XX. during $XX,XXX In were fourth in to compared $XXX,XXX indeed to the whole, net decreasing This sequentially. in fiscal resulted 'XX compared quarter, to On revenue 'XX
I know believe, I for have at this and out here. that bottomed can However, grow -- and levels said from here we I've these before, do
portfolio us early We've pediatric track, back get we the on give we products payer back the taken commercial and remain us of but 'XX. about that prospects. time confidence initiatives some implemented can the than first growth channel signs the months pediatric across get to fiscal has more a during X of number It issues to growth anticipated optimistic that with
from least. are For pediatric unit very products, the encouraging shipments XXX% say through X is July up to yesterday, which
a in increase securing improved we've reimbursement both the initiatives lives and around multivitamin of as and put franchise, efforts. those result seen place a We carbinoxamine covered numerous significant for in
prescribing increasing with promotion dispensing force physician products way good we're pediatric pharmacy already we're of and by our sales materially ordering, reordering. as both seeing early and such, traction As our customer
to discussed. increased changes lives We've payer covered due were areas our lost previously we've that in the
coverage, as to So we share areas promotion significant improvements. had regain previously some via in wins, realize we're we have beginning areas. we're payer exciting areas coverage those Also, and grow resourcing resource direct where those and have to also didn't we now very
long pediatric products to the we again to but abilities the point to once for believe growing and have confident continue back way company. our the those can acknowledge I we back a meaningful very we with be to get revenue being go collective those the portfolio. get at to were contributors levels in of We win to
we're though, our having. now rebuilding For impact excited are about efforts the
the Much program. our result achieved RxConnect we've success important an best-in-class been is and we a of past of the few has efforts part during of that support which commercial platform, years patient believe is our a
patient-centric more our pay and brands. no and program, boast pricing clear guarantee provider access Our for which through than we
It works partner our of the out-of-pocket X,XXX-plus reduce our deliver brands, hassles to directly through for our treatments significantly nationwide predictability and prescribing our pharmacies need for patients customers. costs who ensuring
infrastructure can RxConnect to we evaluate platform we ways and as of go growth forward. unique continue Looking forward, the drive our will leverage to commercial capabilities we
objective improve over Mark, turn past and in years. few I EBITDA fiscal financial million I before pleased. positive $X.X We've the it's We 'XX done the our to couldn't more over the had Aytu been this up transitioned business things just million with with a that wrap adjusted it be $XX.X one that, negative year. To of profile to in
at has this terms refinanced from company. on time steady to $XX over million favorable also we've paid of on hand June cash down our and while million with end remained loan down the more the balance Our term over million to it $XX $XX
levels change fiscal Our about ADHD had portfolio up significant has script over from positive growth a step preshortage 'XX. XX% with
us bottom year-over-year sequentially, portfolio we're impacted achieve adjusted the current yesterday is our levels up flowed expect our beginning we While release in show revenue the indicated net line, basis, impact in our go a fiscal providing our progress. EBITDA level over with to from first the of shipped XXXX. a through I'm in months forward. the through we with X to on units negatively and 'XX EBITDA progress which confident our And pediatric earlier, as plans high optimism in of through fiscal growth which as and XXX% fully
Let me before things up then and to I'll Mark? turning turn questions. Mark, wrap the call to to over back come it over briefly
